Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ebesanar (RHEACELL)
- Development stage
- Unknown
- Lead developer
- RHEACELL
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intramuscular
01
Overview
Ebesanar (allo-APZ2) is an allogeneic cell therapy consisting of mesenchymal stem cells (MSCs) that express the ATP-binding cassette member B5 (ABCB5) marker. Developed by RHEACELL, these cells are derived from human donor skin (dermal MSCs). ABCB5+ MSCs possess potent immunomodulatory and pro-angiogenic properties. In the context of Peripheral Arterial Occlusive Disease (PAOD), the cells are administered intramuscularly to promote wound healing of chronic ulcers and improve blood flow by modulating inflammation and stimulating tissue regeneration. The ABCB5 marker is used to isolate a specific subpopulation of MSCs that exhibit enhanced therapeutic potential compared to non-selected MSCs.
- Other names
- allogeneic ABCB5-positive mesenchymal stem cellsABCB5-positive dermal mesenchymal stem cellsABCB-5-positive dermal mesenchymal stem cellsABCB 5-positive dermal mesenchymal stem cellsABCB5+ MSCs
Beyond the preview
Go deeper on ebesanar (RHEACELL).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ebesanar (RHEACELL).